OCLG OTC
Oncologix Tech Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -86.7%
5Y: -95.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$24K
+0.0% ▲
Capital Expenditures
$913
+0.0% ▲
5Y CAGR: -11.5%
Free Cash Flow
-$25K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$29K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$653K | -$1M | -$3M | -$2M | -$2M |
| Depreciation & Amort. | $6K | $23K | $19K | $17K | $15K |
| Stock-Based Comp. | $0 | $91K | $0 | $0 | $0 |
| Change in Working Capital | $639K | -$277K | $492K | $837K | $2M |
| Other Non-Cash Items | $155K | $941K | $1M | $610K | -$914K |
| Operating Cash Flow | $147K | -$630K | -$357K | $345K | -$24K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$878 | -$3K | $0 | -$913 |
| Acquisitions (Net) | -$324K | -$66K | -$561K | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$324K | -$67K | -$564K | $0 | -$913 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $665K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $215K | $0 | $928K | -$310K | -$4K |
| Financing Cash Flow | $215K | $675K | $928K | -$310K | -$4K |
| Net Change in Cash | $38K | -$22K | $7K | $35K | -$29K |
| Cash End of Period | $39K | $18K | $25K | $60K | $31K |
| Free Cash Flow | $147K | -$631K | -$360K | $345K | -$25K |